We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NXL:NASDAQNexalin Technology, Inc. analysis

Data as of Sep 27, 2026 - not real-time

Latest price
$4.39
Risk: high
9/10High risk

Summary

Nexalin Technology, Inc. is priced at $4.39 and its moving averages line up in bearish order, the shorter trailing the longer. It has lost 58.2% over the past 30 days. With RSI at 27.9 the momentum picture is oversold, alongside a bullish MACD signal. Watch $4.00 as support and $7.80 as the nearer resistance level.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. The average analyst target implies 1266.7% above today's level. Revenue is contracting at 82.8%.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 90.4%, a beta of 1.31 and a maximum drawdown of 92.3%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 2/10.

Top market events

  • Detailed price information for Nexalin Technology Inc NXL-Q from The Globe and Mail including charting and trades.
  • Yahoo Finance15dAnixa Biosciences and Nexalin Technology Interviews to Air Nationally on the RedChip Small Stocks, Big...

Market outlook

Short term

< 1 year

Neutral

Model confidence1/101 out of 10

Key factors

  • Short-term moving averages stacked below long-term ones
  • RSI at 27.9 signals oversold conditions
  • Trading below the 200-day average of 13.31

Medium term

1–3 years

Neutral

Model confidence1/101 out of 10

Key factors

  • Short-term moving averages stacked below long-term ones
  • RSI at 27.9 signals oversold conditions
  • Trading below the 200-day average of 13.31

Long term

> 3 years

Neutral

Model confidence2/102 out of 10

Key factors

  • Analyst targets imply +1266.7% versus the current price
  • Negative return on equity of -240.3%
  • Revenue contracting at -82.8%

Key metrics

Financial health

Revenue Growth-82.80%
P/E Ratio-0.5
ROE-240.25%
ROA-119.22%
P/B Ratio2.1
Op. Cash Flow$-6128895
Free Cash Flow$-2533424
Industry P/E30.5

Technical analysis

TrendBearish
RSI27.9
Support$4.00
Resistance$7.80
MA 20$5.24
MA 50$8.72
MA 200$13.31
MACDBullish
VolumeDecreasing
Fear & Greed Index94.88

Valuation

Target Price$60.00
Upside/Downside1266.74%
GradeFair
TypeBlend

Risk assessment

Beta1.31
Volatility90.37%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.